NCT00015340View on ClinicalTrials.gov

Buprenorphine/Naloxone in the Treatment of Heroin Dependence - 14

PHASE4CompletedINTERVENTIONAL
Enrollment

582

Participants

Timeline

Start Date

August 31, 1999

Primary Completion Date

August 31, 2001

Study Completion Date

September 30, 2001

Conditions
Opioid DependenceSubstance-Related Disorders
Interventions
DRUG

Buprenorphine/naloxone

Trial Locations (5)

10010

New York VAMC, New York

33612

VA Medical Center, Tampa

60141

VA Medical Center, Hines

90095

University of California, Los Angeles

98108

VA PUget Sound Helath Care System, Seattle

All Listed Sponsors
collaborator

New York MDRU

OTHER

lead

National Institute on Drug Abuse (NIDA)

NIH

NCT00015340 - Buprenorphine/Naloxone in the Treatment of Heroin Dependence - 14 | Biotech Hunter | Biotech Hunter